Henry Schein, Inc. (0L3C.L)
USD 72.28
(-1.94%)
USD 72.28
(-1.94%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.93 Billion USD | -0.54% |
| 2022 | 2.95 Billion USD | 4.99% |
| 2021 | 2.81 Billion USD | 25.18% |
| 2020 | 2.24 Billion USD | -4.71% |
| 2019 | 2.35 Billion USD | -12.73% |
| 2018 | 2.7 Billion USD | 6.38% |
| 2017 | 2.53 Billion USD | 5.1% |
| 2016 | 2.41 Billion USD | 7.72% |
| 2015 | 2.24 Billion USD | 2.15% |
| 2014 | 2.19 Billion USD | 10.98% |
| 2013 | 1.97 Billion USD | 5.64% |
| 2012 | 1.87 Billion USD | 2.04% |
| 2011 | 1.83 Billion USD | 12.12% |
| 2010 | 1.63 Billion USD | 12.95% |
| 2009 | 1.44 Billion USD | 0.56% |
| 2008 | 1.44 Billion USD | 8.23% |
| 2007 | 1.33 Billion USD | 13.35% |
| 2006 | 1.17 Billion USD | 13.45% |
| 2005 | 1.03 Billion USD | 19.98% |
| 2004 | 863.31 Million USD | 24.49% |
| 2003 | 693.47 Million USD | 15.84% |
| 2002 | 598.63 Million USD | 8.53% |
| 2001 | 551.57 Million USD | -0.45% |
| 2000 | 554.05 Million USD | -8.78% |
| 1999 | 607.4 Million USD | 15.56% |
| 1998 | 525.6 Million USD | 30.49% |
| 1997 | 402.8 Million USD | 80.22% |
| 1996 | 223.5 Million USD | 13.11% |
| 1995 | 197.6 Million USD | 26.67% |
| 1994 | 156 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 781 Million USD | -1.26% |
| 2024 Q1 | 791 Million USD | -1.98% |
| 2023 Q1 | 761 Million USD | -5.58% |
| 2023 Q3 | 784 Million USD | 3.7% |
| 2023 Q4 | 807 Million USD | 2.93% |
| 2023 FY | 2.93 Billion USD | -0.54% |
| 2023 Q2 | 756 Million USD | -0.66% |
| 2022 Q1 | 729 Million USD | -5.86% |
| 2022 FY | 2.95 Billion USD | 4.99% |
| 2022 Q4 | 806 Million USD | 24.38% |
| 2022 Q3 | 648 Million USD | -4.71% |
| 2022 Q2 | 680 Million USD | -6.72% |
| 2021 Q4 | 774.36 Million USD | 10.39% |
| 2021 FY | 2.81 Billion USD | 25.18% |
| 2021 Q1 | 657.99 Million USD | -2.39% |
| 2021 Q2 | 678.8 Million USD | 3.16% |
| 2021 Q3 | 701.49 Million USD | 3.34% |
| 2020 Q2 | 445.79 Million USD | -21.43% |
| 2020 Q4 | 674.13 Million USD | 20.46% |
| 2020 Q3 | 559.63 Million USD | 25.54% |
| 2020 FY | 2.24 Billion USD | -4.71% |
| 2020 Q1 | 567.38 Million USD | -7.79% |
| 2019 Q4 | 615.32 Million USD | 7.06% |
| 2019 FY | 2.35 Billion USD | -12.73% |
| 2019 Q1 | 574.6 Million USD | -14.84% |
| 2019 Q2 | 593.21 Million USD | 3.24% |
| 2019 Q3 | 574.77 Million USD | -3.11% |
| 2018 Q4 | 674.73 Million USD | 1.01% |
| 2018 Q2 | 677.21 Million USD | -1.24% |
| 2018 Q1 | 685.68 Million USD | 3.93% |
| 2018 Q3 | 668.01 Million USD | -1.36% |
| 2018 FY | 2.7 Billion USD | 6.38% |
| 2017 FY | 2.53 Billion USD | 5.1% |
| 2017 Q4 | 659.76 Million USD | 5.99% |
| 2017 Q2 | 628.51 Million USD | -0.07% |
| 2017 Q3 | 622.5 Million USD | -0.96% |
| 2017 Q1 | 628.95 Million USD | -0.45% |
| 2016 Q3 | 583.4 Million USD | -3.13% |
| 2016 Q1 | 599.05 Million USD | 2.2% |
| 2016 Q2 | 602.25 Million USD | 0.53% |
| 2016 Q4 | 631.79 Million USD | 8.3% |
| 2016 FY | 2.41 Billion USD | 7.72% |
| 2015 Q3 | 551.58 Million USD | -1.58% |
| 2015 Q1 | 545.16 Million USD | -2.91% |
| 2015 Q2 | 560.42 Million USD | 2.8% |
| 2015 Q4 | 586.17 Million USD | 6.27% |
| 2015 FY | 2.24 Billion USD | 2.15% |
| 2014 FY | 2.19 Billion USD | 10.98% |
| 2014 Q1 | 539.44 Million USD | 5.23% |
| 2014 Q2 | 547.62 Million USD | 1.52% |
| 2014 Q3 | 547.57 Million USD | -0.01% |
| 2014 Q4 | 561.52 Million USD | 2.55% |
| 2013 Q3 | 479.17 Million USD | -2.96% |
| 2013 Q4 | 512.63 Million USD | 6.98% |
| 2013 Q2 | 493.79 Million USD | 0.09% |
| 2013 Q1 | 493.36 Million USD | 2.32% |
| 2013 FY | 1.97 Billion USD | 5.64% |
| 2012 Q3 | 459.42 Million USD | -1.48% |
| 2012 Q4 | 482.15 Million USD | 4.95% |
| 2012 Q1 | 465.45 Million USD | -4.86% |
| 2012 FY | 1.87 Billion USD | 2.04% |
| 2012 Q2 | 466.33 Million USD | 0.19% |
| 2011 Q3 | 444.15 Million USD | -3.66% |
| 2011 Q2 | 461 Million USD | 4.41% |
| 2011 Q4 | 489.21 Million USD | 10.14% |
| 2011 FY | 1.83 Billion USD | 12.12% |
| 2011 Q1 | 441.52 Million USD | 2.03% |
| 2010 Q2 | 407.63 Million USD | 2.68% |
| 2010 FY | 1.63 Billion USD | 12.95% |
| 2010 Q4 | 432.74 Million USD | 8.16% |
| 2010 Q3 | 400.08 Million USD | -1.85% |
| 2010 Q1 | 396.98 Million USD | 1.88% |
| 2009 FY | 1.44 Billion USD | 0.56% |
| 2009 Q1 | 346.08 Million USD | 2.59% |
| 2009 Q2 | 356.2 Million USD | 2.92% |
| 2009 Q3 | 362.38 Million USD | 1.73% |
| 2009 Q4 | 389.65 Million USD | 7.53% |
| 2008 Q4 | 337.32 Million USD | -7.15% |
| 2008 FY | 1.44 Billion USD | 8.23% |
| 2008 Q2 | 375.05 Million USD | 2.47% |
| 2008 Q1 | 366 Million USD | 1.91% |
| 2008 Q3 | 363.3 Million USD | -3.13% |
| 2007 Q3 | 332.63 Million USD | 3.01% |
| 2007 Q1 | 319.07 Million USD | 0.52% |
| 2007 Q4 | 359.14 Million USD | 7.97% |
| 2007 FY | 1.33 Billion USD | 13.35% |
| 2007 Q2 | 322.92 Million USD | 1.21% |
| 2006 Q3 | 298.33 Million USD | 5.52% |
| 2006 Q4 | 317.43 Million USD | 6.4% |
| 2006 Q2 | 282.71 Million USD | 2.18% |
| 2006 Q1 | 276.68 Million USD | -4.01% |
| 2006 FY | 1.17 Billion USD | 13.45% |
| 2005 Q1 | 248.98 Million USD | -7.71% |
| 2005 Q2 | 253.94 Million USD | 1.99% |
| 2005 Q3 | 253.59 Million USD | -0.14% |
| 2005 Q4 | 288.24 Million USD | 13.66% |
| 2005 FY | 1.03 Billion USD | 19.98% |
| 2004 Q2 | 188.13 Million USD | 1.95% |
| 2004 Q3 | 220.87 Million USD | 17.4% |
| 2004 FY | 863.31 Million USD | 24.49% |
| 2004 Q4 | 269.78 Million USD | 22.15% |
| 2004 Q1 | 184.52 Million USD | -5.21% |
| 2003 Q2 | 164.49 Million USD | 3.32% |
| 2003 Q1 | 159.21 Million USD | 0.86% |
| 2003 Q3 | 175.1 Million USD | 6.44% |
| 2003 FY | 693.47 Million USD | 15.84% |
| 2003 Q4 | 194.66 Million USD | 11.17% |
| 2002 Q1 | 143.19 Million USD | -5.3% |
| 2002 FY | 598.63 Million USD | 8.53% |
| 2002 Q4 | 157.84 Million USD | 3.72% |
| 2002 Q3 | 152.18 Million USD | 4.66% |
| 2002 Q2 | 145.4 Million USD | 1.55% |
| 2001 FY | 551.57 Million USD | -0.45% |
| 2001 Q1 | 158.11 Million USD | 91.94% |
| 2001 Q2 | 131.62 Million USD | -16.76% |
| 2001 Q3 | 136.98 Million USD | 4.07% |
| 2001 Q4 | 151.19 Million USD | 10.38% |
| 2000 Q2 | 159.18 Million USD | 3.6% |
| 2000 FY | 554.05 Million USD | -8.78% |
| 2000 Q1 | 153.65 Million USD | -4.98% |
| 2000 Q3 | 158.83 Million USD | -0.22% |
| 2000 Q4 | 82.37 Million USD | -48.13% |
| 1999 Q1 | 146.8 Million USD | 9.31% |
| 1999 Q4 | 161.7 Million USD | 8.31% |
| 1999 Q3 | 149.3 Million USD | -0.33% |
| 1999 Q2 | 149.8 Million USD | 2.04% |
| 1999 FY | 607.4 Million USD | 15.56% |
| 1998 Q1 | 110.8 Million USD | -33.05% |
| 1998 Q2 | 116.1 Million USD | 4.78% |
| 1998 Q4 | 134.3 Million USD | -0.67% |
| 1998 Q3 | 135.2 Million USD | 16.45% |
| 1998 FY | 525.6 Million USD | 30.49% |
| 1997 Q2 | 70.7 Million USD | 5.37% |
| 1997 FY | 402.8 Million USD | 80.22% |
| 1997 Q1 | 67.1 Million USD | 8.58% |
| 1997 Q4 | 165.5 Million USD | 97.73% |
| 1997 Q3 | 83.7 Million USD | 18.39% |
| 1996 Q4 | 61.8 Million USD | 9.77% |
| 1996 FY | 223.5 Million USD | 13.11% |
| 1996 Q1 | 51.9 Million USD | 108.41% |
| 1996 Q2 | 53.3 Million USD | 2.7% |
| 1996 Q3 | 56.3 Million USD | 5.63% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q4 | -617.2 Million USD | 0.0% |
| 1995 FY | 197.6 Million USD | 26.67% |
| 1995 Q1 | - USD | 100.0% |
| 1995 Q3 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 FY | 156 Million USD | 0.0% |
| 1994 Q4 | -496.1 Million USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -694.125% |
| Accuray Incorporated | 142.61 Million USD | -1959.362% |
| Align Technology, Inc. | 2.07 Billion USD | -41.418% |
| Elevance Health Inc. | 36.23 Billion USD | 91.895% |
| AxoGen, Inc. | 149.33 Million USD | -1866.706% |
| Boston Scientific Corporation | 7.5 Billion USD | 60.871% |
| CVS Health Corporation | 40.68 Billion USD | 92.782% |
| Cardinal Health, Inc. | 5 Billion USD | 41.26% |
| Centene Corporation | 138.33 Billion USD | 97.877% |
| DaVita Inc. | 1.47 Billion USD | -99.256% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 93.536% |
| Hologic, Inc. | 1.26 Billion USD | -131.698% |
| Humana Inc. | 102.36 Billion USD | 97.131% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -168.749% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | -45.295% |
| Masimo Corporation | 867 Million USD | -238.754% |
| McKesson Corporation | 8.67 Billion USD | 66.144% |
| Patterson Companies, Inc. | 1.12 Billion USD | -160.53% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | -82.422% |
| ResMed Inc. | 1.36 Billion USD | -114.634% |
| Teladoc Health, Inc. | 2.09 Billion USD | -40.463% |
| Universal Health Services, Inc. | 9.2 Billion USD | 68.105% |
| Veeva Systems Inc. | 1.25 Billion USD | -133.643% |
| Baxter International Inc. | 5.27 Billion USD | 44.291% |
| Becton, Dickinson and Company | 6.71 Billion USD | 56.243% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 0.867% |
| Danaher Corporation | 8.75 Billion USD | 66.453% |
| Stryker Corporation | 9.2 Billion USD | 68.107% |
| Medtronic plc | 16.12 Billion USD | 81.791% |